123 related articles for article (PubMed ID: 22828207)
1. Associations between testosterone levels and incident prostate, lung, and colorectal cancer. A population-based study.
Hyde Z; Flicker L; McCaul KA; Almeida OP; Hankey GJ; Chubb SA; Yeap BB
Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1319-29. PubMed ID: 22828207
[TBL] [Abstract][Full Text] [Related]
2. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
[TBL] [Abstract][Full Text] [Related]
3. Circulating steroid hormones and the risk of prostate cancer.
Severi G; Morris HA; MacInnis RJ; English DR; Tilley W; Hopper JL; Boyle P; Giles GG
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):86-91. PubMed ID: 16434592
[TBL] [Abstract][Full Text] [Related]
4. Thyroid function and cancer risk: a prospective population study.
Hellevik AI; Asvold BO; Bjøro T; Romundstad PR; Nilsen TI; Vatten LJ
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):570-4. PubMed ID: 19155436
[TBL] [Abstract][Full Text] [Related]
5. Higher Dihydrotestosterone Is Associated with the Incidence of Lung Cancer in Older Men.
Chan YX; Alfonso H; Chubb SA; Handelsman DJ; Fegan PG; Hankey GJ; Golledge J; Flicker L; Yeap BB
Horm Cancer; 2017 Apr; 8(2):119-126. PubMed ID: 28233278
[TBL] [Abstract][Full Text] [Related]
6. Endogenous sex hormones and prostate cancer risk: a case-control study nested within the Carotene and Retinol Efficacy Trial.
Chen C; Weiss NS; Stanczyk FZ; Lewis SK; DiTommaso D; Etzioni R; Barnett MJ; Goodman GE
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1410-6. PubMed ID: 14693730
[TBL] [Abstract][Full Text] [Related]
7. Folate levels and cancer morbidity and mortality: prospective cohort study from Busselton, Western Australia.
Rossi E; Hung J; Beilby JP; Knuiman MW; Divitini ML; Bartholomew H
Ann Epidemiol; 2006 Mar; 16(3):206-12. PubMed ID: 16343942
[TBL] [Abstract][Full Text] [Related]
8. Prediagnostic serum hormones and the risk of prostate cancer.
Nomura A; Heilbrun LK; Stemmermann GN; Judd HL
Cancer Res; 1988 Jun; 48(12):3515-7. PubMed ID: 3370644
[TBL] [Abstract][Full Text] [Related]
9. Endogenous sex hormones and the risk of prostate cancer: a prospective study.
Weiss JM; Huang WY; Rinaldi S; Fears TR; Chatterjee N; Hsing AW; Crawford ED; Andriole GL; Kaaks R; Hayes RB
Int J Cancer; 2008 May; 122(10):2345-50. PubMed ID: 18172860
[TBL] [Abstract][Full Text] [Related]
10. Hormonal predictors of prostate cancer.
Sofikerim M; Eskicorapci S; Oruç O; Ozen H
Urol Int; 2007; 79(1):13-8. PubMed ID: 17627161
[TBL] [Abstract][Full Text] [Related]
11. Endogenous sex hormones and prostate cancer: a quantitative review of prospective studies.
Eaton NE; Reeves GK; Appleby PN; Key TJ
Br J Cancer; 1999 Jun; 80(7):930-4. PubMed ID: 10362098
[TBL] [Abstract][Full Text] [Related]
12. Sex hormone-binding globulin is a significant predictor of extracapsular extension in men undergoing radical prostatectomy.
Salonia A; Gallina A; Briganti A; Zanni G; Suardi N; Capitanio U; Colombo R; Bertini R; Freschi M; Guazzoni G; Rigatti P; Montorsi F
BJU Int; 2011 Apr; 107(8):1243-9. PubMed ID: 20883480
[TBL] [Abstract][Full Text] [Related]
13. Lower TSH and higher free thyroxine predict incidence of prostate but not breast, colorectal or lung cancer.
Chan YX; Knuiman MW; Divitini ML; Brown SJ; Walsh J; Yeap BB
Eur J Endocrinol; 2017 Oct; 177(4):297-308. PubMed ID: 28684452
[TBL] [Abstract][Full Text] [Related]
14. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
15. Androgens and prostate cancer risk: a prospective study.
Wirén S; Stocks T; Rinaldi S; Hallmans G; Bergh A; Stenman UH; Kaaks R; Stattin P
Prostate; 2007 Aug; 67(11):1230-7. PubMed ID: 17562541
[TBL] [Abstract][Full Text] [Related]
16. In older men, lower plasma 25-hydroxyvitamin D is associated with reduced incidence of prostate, but not colorectal or lung cancer.
Wong YY; Hyde Z; McCaul KA; Yeap BB; Golledge J; Hankey GJ; Flicker L
PLoS One; 2014; 9(6):e99954. PubMed ID: 24949795
[TBL] [Abstract][Full Text] [Related]
17. Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy.
Parsons JK; Carter HB; Platz EA; Wright EJ; Landis P; Metter EJ
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2257-60. PubMed ID: 16172240
[TBL] [Abstract][Full Text] [Related]
18. [Behavior of LH, FSH, total testosterone, free testosterone and SHBG serum levels in the therapy of prostatic cancer with Turisteron (ethinyl estradiol sulfonate)].
Guddat HM; Schnorr D; Dörner G; Stahl F; Rohde W
Z Urol Nephrol; 1987 Dec; 80(12):665-8. PubMed ID: 3126615
[TBL] [Abstract][Full Text] [Related]
19. The protective effect of diabetes mellitus against prostate cancer: role of sex hormones.
Baradaran N; Ahmadi H; Salem S; Lotfi M; Jahani Y; Baradaran N; Mehrsai AR; Pourmand G
Prostate; 2009 Dec; 69(16):1744-50. PubMed ID: 19676082
[TBL] [Abstract][Full Text] [Related]
20. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
